1ZML | pdb_00001zml

Crystal Structure of the Catalytic Domain of Factor XI in complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)phenethyl)guanidine


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 
    0.229 (Depositor), 0.225 (DCC) 
  • R-Value Work: 
    0.203 (Depositor), 0.202 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 1ZML

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.

Lazarova, T.I.Jin, L.Rynkiewicz, M.Gorga, J.C.Bibbins, F.Meyers, H.V.Babine, R.Strickler, J.

(2006) Bioorg Med Chem Lett 16: 5022-5027

  • DOI: https://doi.org/10.1016/j.bmcl.2006.07.043
  • Primary Citation Related Structures: 
    1ZLR, 1ZMJ, 1ZML, 1ZMN

  • PubMed Abstract: 

    A series of functionalized aryl boronic acids were synthesized and evaluated as potential inhibitors of factor XIa. Crystal structures of the protein-inhibitor complexes led to the design and synthesis of second generation compounds showing single digit micromolar inhibition against FXIa and selectivity against thrombin, trypsin, and FXa.


  • Organizational Affiliation
    • Medicinal Chemistry, Daiichi Asubio Medical Research Laboratories, LLC, One Kendall Square, Building 700, Cambridge, MA 02139, USA. tlazarova@medchempartners.com

Macromolecule Content 

  • Total Structure Weight: 27.65 kDa 
  • Atom Count: 2,135 
  • Modeled Residue Count: 237 
  • Deposited Residue Count: 238 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Coagulation factor XI238Homo sapiensMutation(s): 4 
Gene Names: F11
EC: 3.4.21.27
UniProt & NIH Common Fund Data Resources
Find proteins for P03951 (Homo sapiens)
Explore P03951 
Go to UniProtKB:  P03951
PHAROS:  P03951
GTEx:  ENSG00000088926 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP03951
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
412

Query on 412



Download:Ideal Coordinates CCD File
I [auth A](R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE
C12 H18 B N3 O3
ZYCNKSJMJFKCBX-LLVKDONJSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
B [auth A]
C [auth A]
D [auth A]
F [auth A]
G [auth A]
B [auth A],
C [auth A],
D [auth A],
F [auth A],
G [auth A],
H [auth A]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
BCT

Query on BCT



Download:Ideal Coordinates CCD File
E [auth A]BICARBONATE ION
C H O3
BVKZGUZCCUSVTD-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free:  0.229 (Depositor), 0.225 (DCC) 
  • R-Value Work:  0.203 (Depositor), 0.202 (DCC) 
Space Group: I 2 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 121.291α = 90
b = 121.291β = 90
c = 121.291γ = 90
Software Package:
Software NamePurpose
CNXrefinement
HKL-2000data reduction
SCALEPACKdata scaling
CNXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2006-05-09
    Type: Initial release
  • Version 1.1: 2008-04-30
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2021-10-20
    Changes: Database references, Derived calculations
  • Version 1.4: 2023-08-23
    Changes: Data collection, Refinement description
  • Version 1.5: 2024-10-16
    Changes: Structure summary